What's new

According to the new regulation issued from China SDA (State Drug Administration), any foreign company should register at least 2 Class II new drugs before applying its business license, for there are already more than 6,000 pharmaceutical factories in China. Most of them are small and low-technical-level local factories. It is more and more difficult for foreign companies to establish an affiliate in China because it usually takes 2-3 years to register a Class II new drug.

Therefore if a foreign company intends to have a quick access to China market, the most effective way is to acquire a pharmaceutical product available on the market or acquire a local company.

Nestep can seek Chinese partner upon client's request, either for products or for local small factories. With limited investment, you will possess the existing sales net as well as market of your Chinese partner. Of course, your future business in China is booming too.